Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Experimental and Approved Disease-Modifying Therapies Treatment Strategies and Trends Other Interventions Disease Course and Risk Factors For More Information References ECTRIMS Annual Meeting Highlights This edition of MSAA’s “What’s New in MS Research” provides highlights from this year’s European Committee for Treatment […]

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD On October 30, 2019, Biogen Inc. and Alkermes plc announced the United States Food and Drug Administration (FDA) approval of Vumerity™ (diroximel fumarate) oral capsules to treat adults with relapsing forms of multiple sclerosis (MS). This approval includes the treatment of clinically isolated syndrome (CIS), […]

The Multiple Sclerosis Association of America (MSAA), in partnership with Novartis Pharmaceuticals Corporation and Emmy Award-winning television personality and multiple sclerosis (MS) advocate Montel Williams, announced today the launch of My MS Second Act. The educational program aims to improve awareness about MS disease progression and secondary-progressive MS (SPMS) and underscores the need for early […]

The Multiple Sclerosis Association of America (MSAA) is proud to announce a partnership with eSSENTIAL Accessibility, a comprehensive digital accessibility platform to assist in continuing MSAA’s commitment in providing informative and accessible resources to members of the multiple sclerosis (MS) community. Many individuals have difficulty typing, moving a mouse, or reading due to a variety […]

If you have any doubts about the breadth and depth of ongoing research into the causes, nature, and treatment of multiple sclerosis (MS), the 12 items that follow should entirely allay those concerns. This latest edition of “What’s New in MS Research” reports on findings from the depths of the seas to the aisles of your local supermarket, and then to laboratories, hospitals, and MS clinics.

The Multiple Sclerosis Association of America (MSAA) is proud to announce a new Chief Medical Officer (CMO) for the organization. Barry A. Hendin, a highly accomplished neurologist who specializes in MS, has assumed the role. Preceding Dr. Hendin was Jack Burks, MD, a clinical professor of neurology for the Herbert Wertheim College of Medicine at […]

The effort to enhance the lives and health of people with multiple sclerosis (MS) is advancing on many fronts, as researchers explore the impact of approaches ranging from stress management, exercise, diet, stem-cell therapy, and cannabis use, to a variety of approved and investigational disease-modifying therapies (DMTs).

This latest edition of “What’s New in MS Research” features highlights from the annual meetings of the American Academy of Neurology (AAN) and the Consortium of Multiple Sclerosis Centers (CMSC), both held in May of this year.

The Multiple Sclerosis Association of America’s (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since the Summer of 2016. Powered by HealthUnlocked, My MSAA Community was created to offer people with multiple sclerosis, care partners, friends, and family members a way to connect with others also affected by the condition.